|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2300078734 |
|
最近更新日期: Date of Last Refreshed on: |
2023-12-18 09:07:57 |
|
注册时间: Date of Registration: |
2023-12-18 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
绽妍JUYOU重组贻贝粘蛋白速修面膜人体生物功效试验 |
|
Public title: |
Human biological efficacy test of Zhanyan JUYOU recombinant mussel mucin quick repair facial mask |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
绽妍JUYOU重组贻贝粘蛋白速修面膜人体生物功效试验 |
|
Scientific title: |
Human biological efficacy test of Zhanyan JUYOU recombinant mussel mucin quick repair facial mask |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
舒晓红 |
研究负责人: |
王曦 |
|
Applicant: |
Shu Xiaohong |
Study leader: |
Wang Xi |
|
申请注册联系人电话: Applicant telephone: |
+86 28 8542 2075 |
研究负责人电话: Study leader's telephone: |
+86 28 8542 2075 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
susan12311231@126.com |
研究负责人电子邮件: Study leader's E-mail: |
xierwang@126.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
四川省成都市武侯区国学巷37号 |
研究负责人通讯地址: |
四川省成都市武侯区国学巷37号 |
|
Applicant address: |
37 Guoxue Lane, Wuhou District, Chengdu, Sichuan |
Study leader's address: |
37 Guoxue Lane, Wuhou District, Chengdu, Sichuan |
|
申请注册联系人邮政编码: Applicant postcode: |
610041 |
研究负责人邮政编码: Study leader's postcode: |
610041 |
|
申请人所在单位: |
四川大学华西医院 |
||
|
Applicant's institution: |
West China Hospital, Sichuan University |
||
|
研究负责人所在单位: |
四川大学华西医院 |
||
|
Affiliation of the Leader: |
West China Hospital, Sichuan University |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2023年审(1997)号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
四川大学华西医院生物伦理审查委员会 |
||
|
Name of the ethic committee: |
Institutional Ethics Committee of West China Hospital, Sichuan University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-11-29 00:00:00 |
||
|
伦理委员会联系人: |
李娜 |
||
|
Contact Name of the ethic committee: |
Li Na |
||
|
伦理委员会联系地址: |
四川省成都市武侯区国学巷37号 |
||
|
Contact Address of the ethic committee: |
37 Guoxue Lane, Wuhou District, Chengdu, Sichuan |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 28 8542 3237 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
四川大学华西医院 |
||||||||||||||||||||||
|
Primary sponsor: |
West China Hospital, Sichuan University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
四川省成都市武侯区国学巷37号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
37 Guoxue Lane, Wuhou District, Chengdu, Sichuan |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
绽妍生物科技有限公司 |
||||||||||||||||||||||
|
Source(s) of funding: |
Zhanyan Biotechnology Co., Ltd |
||||||||||||||||||||||
|
Target disease: |
Soothing sensitive skin |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
单臂 |
||||||||||||||||||||||
|
Study design: |
Single arm |
||||||||||||||||||||||
|
研究目的: |
以18-60岁,乳酸刺痛试验为阳性的,健康男、女性受试者为对象.使用绽妍JUYOU重组贻贝粘蛋白速修面膜,评价产品的安全性和有效性。 |
||||||||||||||||||||||
|
Objectives of Study: |
Healthy male and female subjects aged 18-60 years old with positive lactic acid tingling test were selected as the subjects. Then, the safety and effectiveness of the product were evaluated by using Zhanyan JUYOU recombinant mussel mucin quick repair facial mask. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1)年龄≥18 岁,≤60岁,男女均可; 2)健康状况良好; 3)乳酸刺痛试验阳性分值合计≥3分; 4)愿意遵守试验要求完成整个试验共计4周,能够按要求完成随访 5)项目知情同意并签订知情同意书和肖像权同意书 |
||||||||||||||||||||||
|
Inclusion criteria |
1) Age ≥ 18 years old, ≤ 60 years old, both male and female; 2) Good health condition; 3) The total positive score of lactate stinging test is ≥ 3 points; 4) Willing to comply with the experimental requirements and complete the entire experiment for a total of 4 weeks, able to complete follow-up as required 5) Informed consent for the project and signing of informed consent and portrait rights consent forms |
||||||||||||||||||||||
|
排除标准: |
1)乳酸刺痛试验阴性; 2)怀孕或者哺乳期女性; 3)皮肤疾病(例如银屑病、湿疹、牛皮癣、皮肤癌等),或测试区域或附近有明显的红斑、晒斑、伤口、磨损、纹身等; 4)3个月内参加过类似的测试; 5)近3个月内使用其他任何抗过敏产品; 6)参加其它的临床试验研究者; 7)专家或专业人士认为有其他医源性原因会影响测试结果。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1) Lactic acid stinging test negative; 2) Pregnant or lactating women; 3) Skin diseases (such as psoriasis, eczema, psoriasis, skin cancer, etc.), or obvious redness, sunburn, wounds, wear, tattoos, etc. in or near the testing area; 4) Participated in similar tests within 3 months; 5) Use any other anti allergic products within the past 3 months; 6) Participate in other clinical trial researchers; 7) Experts or professionals believe that there are other iatrogenic factors that may affect the test results. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-12-18 00:00:00至 To 2024-02-23 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2023-12-18 00:00:00 至 To 2023-12-19 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
无 |
|
Blinding: |
None |
|
是否共享原始数据: IPD sharing |
Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
四川大学华西医院临床试验公共管理平台 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Sichuan University West China Hospital Clinical Trial Public Management Platform |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Record Form, CRF |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |